Tag: Wu Zuolong
Haiwen, Clifford Chance advises Sinopharm’s take-private bid for China-TMC
Sinopharm leads HKD15.6B take-private bid for China-TMC
Sinopharm leads HKD15.6B take-private bid for China-TMC
Preparing for India’s multi-agency dawn raids: Building response architecture, preserving privilege and documenting every step